OXULAR ACQUISITIONS LIMITED
Company number 12798969 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£467,122
Balance sheet as at 2023-10-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-08-07
- Employees
- 0 (2023 accounts)
- Registered office
- The Charter Building, Vine Street, Uxbridge, Middlesex, England, UB8 1JG
- Postcode
- UB8 1JG
- Accounts category
- Micro
Accounts
- Last made up to
- 2024-10-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-08-03
- Next due by
- 2027-08-17
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 7 resigned
Group structure
Controlled by Regeneron Pharmaceuticals, Inc (01226128) — since 2024-11-20
Controlled by OXULAR LIMITED — since 2020-08-07
From persons-with-significant-control filings on the public register.
Contact details
- Website
- oxular.com
Discover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.
Competitors Hayes
-
3. NEOHAIR LTD
This company ranks 7 among research and experimental development on biotechnology in Hayes.
The class of 2020
41%
of the 596 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.
A fact about the year, not a forecast for this company.